LGND
Ligand Pharmaceuticals Incorporated
299.00$
+0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.2% | +45.3% | -13.7% | -15.7% | +3.6% | +130.4% | +11.3% | +10.4% | -5.4% | +3.6% | -46.9% | -1.1% | -33.7% | -33.5% | +61.9% | -14.8% | +0.4% | +146.4% | +106.9% | +12.7% | +11.5% | +87.9% | +18.6% | -8.9% | -4.7% | -41.2% | +3.2% | +19.6% | +65.7% | |
| – | -1.5% | -7.3% | -27.3% | -21.3% | +20.0% | +56.3% | +55.4% | +32.8% | -23.1% | +77.2% | -53.3% | -14.6% | -27.4% | -45.7% | -12.9% | -26.1% | +4.4% | +644.2% | +16.4% | -24.4% | +45.4% | +267.3% | +29.1% | -55.5% | -7.2% | -43.3% | -9.9% | +39.6% | +151.0% | |
| – | +79.0% | -47.4% | -8.8% | -69.2% | +124.9% | +104.5% | +39.1% | +56.4% | -27.7% | +137.3% | -51.5% | -62.6% | -44.2% | -79.1% | +110.4% | +75.8% | +29.1% | +947.2% | +19.7% | -29.6% | +43.0% | +256.2% | -90.0% | -33.4% | -59.0% | +130.5% | -49.0% | +215.0% | +141.9% | |
| – | +79.0% | -47.4% | +43.9% | -49.9% | +59.3% | +70.5% | +54.1% | – | – | +97.7% | -45.1% | -14.6% | -34.0% | -57.4% | -24.9% | -27.3% | +29.1% | +947.2% | +19.7% | -29.6% | +43.0% | +279.1% | +39.9% | -61.6% | -17.0% | -37.9% | -19.6% | +50.4% | +186.3% | |
| – | – | – | – | +654.4% | -23.6% | -24.9% | +159.0% | +61.9% | -32.1% | -25.6% | -8.2% | -15.4% | -14.0% | +32.2% | -9.5% | -28.3% | -26.5% | +108.2% | -14.4% | +53.3% | +64.6% | +89.5% | -25.2% | +41.5% | +55.2% | -61.8% | +12.2% | +8.0% | +43.8% | |
| – | – | – | -8.1% | -0.9% | -33.5% | +28.9% | +70.7% | +42.5% | -20.7% | -58.7% | -371.4% | – | -4,741.0% | – | – | +30.4% | -18.0% | -80.7% | +507.1% | +17.8% | +127.4% | +62.9% | +2.4% | +263.0% | +3.2% | -51.4% | +80.3% | -41.1% | -35.3% | |
| – | – | – | – | – | -11.7% | -0.2% | +143.0% | +0.6% | -4.9% | -75.3% | -48.4% | +350.4% | -34.0% | -93.4% | -18.6% | +73.2% | +10.0% | +0.0% | -57.1% | +389.0% | +131.6% | +27.5% | +33.7% | +100.9% | +126.9% | -16.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -87.0% | +0.0% | +2,027.7% | +357.6% | -4.1% | -3.6% | -3.8% | +357.1% | +13.6% | -2.6% | -68.9% | +99.2% | -44.3% | +0.0% | -2.2% | +1.8% | -3.5% | |
| – | – | – | – | – | -6.8% | +254.7% | -7.2% | -7.6% | +15.2% | -43.4% | – | – | -53.2% | +415.0% | +343.5% | -2.7% | -91.8% | -0.1% | +87.3% | +201.9% | -24.4% | +61.1% | +632.8% | +163.0% | -36.2% | -8.8% | -15.0% | -11.0% | +58.4% | |
| – | +8.1% | +129.0% | -4.3% | +5.2% | +4.0% | +12.1% | +17.3% | +76.9% | +4.2% | -29.7% | -51.7% | +26.1% | -39.5% | -24.9% | +37.7% | -31.6% | -29.2% | +324.0% | -1.7% | +0.5% | +9.4% | +177.3% | +4.0% | -10.3% | -27.0% | -65.3% | -47.8% | +29.0% | +388.1% | |
| – | +57.2% | +24.0% | -23.0% | +37.3% | +11.7% | -3.8% | +77.0% | +301.0% | +8.5% | -27.4% | -70.2% | +38.5% | -26.1% | -31.7% | +22.5% | -18.8% | -18.3% | -21.3% | -8.5% | +990.1% | +5.2% | -65.6% | -79.3% | +488.8% | -58.4% | +137.2% | -83.0% | +121.1% | +0.9% | |
| – | +7.7% | +14.3% | +28.1% | -15.2% | +54.3% | -61.1% | +18.8% | +18.0% | -6.1% | +1,275.2% | -96.0% | +139.4% | -97.5% | +8,728.6% | +24.5% | +48.4% | -38.6% | -96.3% | +60,374.6% | +5.4% | +5.5% | -88.2% | -95.3% | +575.5% | -83.3% | +5,378.4% | -99.5% | +214.6% | -15.1% | |
| – | +161.0% | +15.9% | -56.5% | -29.1% | +40.7% | +122.5% | +57.3% | -7.9% | -11.5% | -20.2% | +3.5% | +15.3% | +15.8% | -49.3% | +28.7% | +47.1% | -4.8% | -50.3% | -47.0% | +123.6% | +5.5% | -56.6% | -42.1% | +56.4% | +122.1% | -36.8% | -54.3% | +115.6% | -38.1% | |
| – | – | – | – | – | +3.8% | +16.5% | +6.7% | +0.6% | -0.5% | -98.7% | -70.9% | +247.4% | – | – | – | -4.3% | -100.0% | – | +1,190.4% | -25.4% | -36.2% | +3,133.8% | +4.8% | -30.8% | -27.5% | – | – | – | – | |
| – | -0.6% | -133.2% | – | – | – | – | -4.4% | -206.5% | – | – | +6.4% | -135.6% | – | -286.7% | – | +206.3% | +87.3% | -47.0% | +1,056.6% | +21.8% | +12.9% | +34.0% | +36.8% | -7.5% | +15.7% | -27.2% | +17.3% | +18.5% | +22.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.0% | +14.6% | +0.4% | +11.6% | -0.8% | +21.9% | |
| – | +15.1% | +21.9% | +16.7% | +18.1% | +6.7% | +16.3% | +2.3% | +4.3% | +0.4% | +8.9% | +21.7% | -2.7% | +18.5% | +4.0% | +0.5% | +0.7% | +4.5% | +3.3% | -1.0% | -1.9% | +12.7% | +2.5% | -17.9% | -18.1% | +6.6% | -2.2% | +5.3% | +3.0% | +11.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.